Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evolving indications for permanent pacing.

D L Hayes1

  • 1Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

The American Journal of Cardiology
|March 25, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.

Heart (British Cardiac Society)·2007
Same author

Non-paroxysmal junctional tachycardia with type I exit block.

Heart (British Cardiac Society)·2002
Same author

Triboelectric simulation of pacemaker malfunction.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2002
Same author

Radiofrequency treatment of hepatic neoplasms in patients with permanent pacemakers.

Mayo Clinic proceedings·2001
Same author

Breath-holding spells associated with significant bradycardia: successful treatment with permanent pacemaker implantation.

Pediatrics·2001
Same author

Left ventricular and biventricular pacing in congestive heart failure.

Mayo Clinic proceedings·2001
Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026
Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026
Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026
Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
See all related articles

Permanent pacemaker indications are expanding, including new uses for hypertrophic cardiomyopathy and dilated cardiomyopathy. Recent guidelines address these expanded applications, alongside controversial pacing for syncope and other specific conditions.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • Permanent pacemaker indications have recently expanded.
  • The American College of Cardiology (ACC) and American Heart Association (AHA) updated guidelines incorporate newer indications.
  • Pacemaker therapy is gaining interest for novel applications.

Purpose of the Study:

  • To review updated ACC/AHA guidelines for permanent pacemaker implantation.
  • To discuss emerging and controversial indications for pacemaker therapy.
  • To contextualize clinical data within recent guideline recommendations.

Main Methods:

  • Review of recent ACC/AHA guidelines for cardiac pacemaker implantation.
  • Discussion of clinical data for newer pacemaker applications.

Related Experiment Videos

  • Analysis of evidence for specific conditions including cardiomyopathies and arrhythmias.

    • Main Results:

    • Updated guidelines include newer indications for permanent pacemakers.
    • Key areas of interest include hypertrophic obstructive cardiomyopathy, dilated cardiomyopathy, and atrial fibrillation prevention.
    • Other considered indications include neurocardiogenic syncope, long QT syndrome, post-cardiac transplantation, and specific cases of atrioventricular block.

    Conclusions:

    • Pacemaker indications continue to evolve with new therapeutic applications.
    • Clinical data supports expanded use in certain cardiomyopathies and arrhythmias.
    • Guidelines provide a framework for evaluating these newer pacemaker indications.